Authors
Conroy lipids
- Elongation of (very) long chain fatty acids - WP4491 (Mus musculus)
- Ether lipid biosynthesis - WP5275 (Homo sapiens)
- Globo series sphingolipid metabolism - WP5305 (Mus musculus)
- Glucocorticoid biosynthesis - WP5280 (Homo sapiens)
- Sebaleic acid formation and metabolism - WP5315 (Homo sapiens)
- Isoglobo series sphingolipids - WP5311 (Homo sapiens)
- Mineralocorticoid biosynthesis - WP5279 (Homo sapiens)
- Steroid hormone precursor biosynthesis - WP5277 (Homo sapiens)
- Estrogen metabolism - WP5276 (Homo sapiens)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- Neolacto series sphingolipid metabolism - WP5302 (Homo sapiens)
- Lacto series sphingolipid metabolism - WP5303 (Homo sapiens)
- Ganglio series sphingolipid metabolism - WP5299 (Homo sapiens)
- Glycosphingolipid metabolism - WP5292 (Homo sapiens)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4346 (Mus musculus)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- Sphingolipid metabolism: integrated pathway - WP4726 (Homo sapiens)
- Omega-3 / omega-6 fatty acid synthesis - WP4723 (Homo sapiens)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4719 (Homo sapiens)
- Sphingolipid metabolism (integrated pathway) - WP4690 (Mus musculus)
- Omega-9 fatty acid synthesis - WP4351 (Mus musculus)
- Omega-3 / omega-6 fatty acid synthesis - WP4350 (Mus musculus)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4347 (Mus musculus)
- Glycerolipids and glycerophospholipids - WP4345 (Mus musculus)
- Brassinolide biosynthetic pathway - WP2634 (Arabidopsis thaliana)
- Eicosanoid synthesis - WP167 (Homo sapiens)
- Mitochondrial beta-oxidation - WP5241 (Homo sapiens)
- Bacterial ceramide synthesis - WP5271 (Caulobacter vibrioides)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- Glycerophospholipid biosynthetic pathway - WP2533 (Homo sapiens)